CeloNova BioSciences Receives Expanded Indication for Benign Prostatic Hyperplasia BPH Bioportfolio, 14 Jan 2015 CeloNova BioSciences Inc. today announced that it has received an expanded indication CE Mark in Europe for its EMBOZENETM…